Japan Approves Biosimilar Teriparatide And Darbepoetin
Executive Summary
Japan’s first biosimilar teriparatide has been approved for Mochida Pharmaceutical, while competition in the darbepoetin alfa arena looks set to step up following two recent authorizations.